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I

Abstract
In this study, the usage of 3D printed polycaprolactone (PCL) constructed supports with nonuniform internal structure and varied mechanical properties was applied to cartilage tissue
engineering (CTE) operations. The fabricated structure can be utilized as structural support for
engineering functional tissue grafts of clinically relevant size, such as auricular tissue. The design
of auricular scaffolds using Computed tomography (CT scan) images with computer-aided design
(CAD) was performed. The feasibility of using 3-dimensional (3D) printing methods for fabrication
of such structures was investigated to mimic the mechanical characteristics of human auricular
cartilage. A series of mechanical tests were performed to calculate the modulus of elasticity of
printed structures. A range of tensile moduli for the uniform internal structures of between 4 –
13 MPa, which is close to human articular tissue (16 ± 3.3 MPa), was obtained. Moreover, a threedimensional finite element analysis (FEA) was conducted for evaluating a complete stress analysis
of an ear structure. The deformation responses of the 3D simulation mimicked the compression
behaviour of 3D printed ear structure.
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1.

Introduction

1.1.

Microtia

Microtia, a Greek word which means ‘little ear’, is a well-known genetic disorder in which babies are
born without or with an under-developed ear[1]. Microtia can show up in isolation or as a feature of
other disorders such as Treacher Collins or Hemifacial micro-somia syndrome[1]. Defects like these
are also common parts of isotretinoin[2] and thalidomide[3] embryopathies. Therefore, they might be
of special concern in studies of other possible teratogenic aspects, such as drugs. In its most severe
shape, microtia is represented by total or almost complete lack of external ears[4]. Currently, the
common surgical technique for remaking of ear is by utilizing autologous rib cartilage[5]. The first step
to create a framework includes modelling and connecting together the rib cartilage to imitate a new
ear[5]. This technique has some complications; including the necessity to delay any surgery until the
patient is at an age of between 6 to 10 years[5]. In order to offer earlier surgical intervention and avoid
removing costal cartilage, currently alloplastic materials are being utilized to reconstruct the ear.
There are a number of advantages of using synthetic materials; such as mass production with different
predesigned sizes and shapes, as well as decreasing the demand on donors[6]. The bulk properties
and surface of the synthetic ear should be proper to allow for good tissue angiogenesis and
integration[7]. The mechanical property of the material is one of the most important specifications of
the material. Studies show that a synthetic material should have an elastic modulus similar to the
tissue it is substituting, to avoid mechanical disparity[8].

1.2.

3D printing of ear structure

The human outer ear consists of primarily fat tissue and elastic cartilage in a complex organization
that is difficult to be reconstituted [9]. In external ear regeneration, reconstruction of the ear auricular
tissue has been considered by using a combination of tissue engineering and bioprinting approaches
(extrusion based printing) [10]. Researchers have used a rapid prototyping technology to fabricate
ear-shape moulds to aid in ear reconstruction [11]. Extrusion based 3D printing technology has also
been applied for 3D printing cell-laden structures in an external ear shape. However, mimicking the
structural and mechanical characteristics of the human outer ear, which is the key to re-establishing
the biological functions, imposes substantial challenges like cartilage formation, keeping the shape of
structure during in vitro, and the scaffold degradation speed [12][13]. In this project, for the first time,
the effect of non-uniform internal structure on the mechanical properties of different sections of an
ear scaffold is investigated.
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1.3.

Additive manufacturing in 3D printing

Additive manufacturing (AM) has emerged as one of the standard fabrication techniques in the past
three decades. In this method, components are built by generating a 3D model using a computeraided design (CAD) and adding materials in a layer-by-layer fashion to make the final model. Printing
can be done without using any additional equipment or tools like fixtures, coolants, or cutting tools
which are needed in the traditional manufacturing techniques. Moreover, in the AM techniques, the
model can be custom designed and optimised before starting the manufacturing [14]. It also allows
easier control on process parameters, such as strand alignment, strand spacing and size, and offers
multipurpose pore geometry, reproducibility, and 100% pore-interconnectivity without using
solvents[15]. Subsequently, it helps users to modify load-bearing and mechanical properties of the
structures to imitate the architecture of tissues in a way which is not possible with ordinary
manufacturing systems[16][17].

1.4.

Scaffolding in tissue engineering

Bioprinting has been extensively used for fabrication of scaffolding structures for specific tissue
constructs. A scaffold should be able to seamlessly integrate with its surrounding tissue and supply
the initial 3D structural support that enables cell attachment, growth, proliferation, differentiation
and forming their extracellular matrix (ECM). This requires the structure to be able to simulate the
framework and morphology of the natural tissue [18]. Research has shown that isolated cells without
initial structural support are unable to form physiologically and mechanically appropriate neotissues
[19]. Therefore, 3D porous bioresorbable scaffolds are being used as a practical biofabrication
approach to tissue-engineered constructs. Extrusion based 3D printing is one of the popular methods
in bio-printing to fabricate scaffolds by extruding small filaments or streams of polymers which solidify
instantly to shape layers.

1.5.

Internal porous structures

Scaffold material and internal porous structure and mechanical properties can play important roles in
regenerating structure, tissue type, and function[20]. Many studies have been done on the effects of
porosity and pore size of the structure[20][21] which show that the porosity of the scaffold is
specifically related to its pore geometrical arrangement , strand orientation (SO), strand spacing (SS),
and strand size (SZ)[22][16] [23]. Olubamiji et al. conducted a research to observe the effects of pore
geometrical configuration on mechanical properties and porosity of 3D printed PCL structure. They
showed that the pore geometrical configurations of SS, SZ and SO scaffolds have an effect on tensile
and compressive moduli, and on the porosity of 3D printed PCL structures, and exhibited an inverse
linear relationship between porosity and mechanical properties. Also the comparison of the results
with a real human articular cartilage indicated that the 3D-printed PCL scaffold could have the
2

promising potential for imitating the mechanical behaviour of actual human articular cartilage. [24].
In another research, the influence of molecular weight on mechanical properties of biomaterials and
structures was investigated and revealed that by increasing the molecular weight, the strength or
mechanical properties were increased; such as yield stress, elastic modulus, and fracture toughness
of different materials ][25][26][27].

1.6.

Polycaprolactone in Tissue Engineering

Different types of biomaterials, such as metals, composites, bio-ceramics, and biopolymers have been
used in tissue engineering to provide 3D structural support. PCL is one of the materials that have
received a lot of attention, in particular in engineering large tissue constructs. PCL is a biocompatible
and biodegradable semicrystalline polymer which is applied in a range of biomedical applications.
Since constructing 3D scaffolds that are capable of imitating biological and mechanical properties of
human articular cartilages is one of the main challenges in cartilage tissue engineering (CTE)[28], it is
worthwhile to deeply consider how to optimize the mechanical properties of the printed scaffolds
while there is little research done in this field in CTE process [24]. Although most researchers are
concentrating on PCL-based hybrid constructs for CTE applications, this project focuses on the PCL
[29].
PCL is composed of a polyester hexanoate backbone, and made by chain-growth polymerization of εcaprolactone by using a catalyst like stannous octoate (Fig.1)[30]. PCL is considered to be semicrystalline to a degree close to 69% [31]. This material is extremely soluble in dichloromethane,
benzene, carbon tetrachloride, toluene, cyclohexanone, chloroform, and 2-nitropropane; lightly
soluble in acetone, 2-butanone, ethyl acetate, dimethylformamide and acetonitrile; and insoluble in
diethyl ether, petroleum ether, alcohols and water [32]. PCL is biodegradable, with a degradation
profile ranging from a few months to a few years, depending on its molecular weight and the degree
of crystallinity. One use of PCL is in biomedical practices because of its soft and hard-tissue
compatibility. For instance, it has been used for resorbable structures, drug delivery systems, and
scaffolds for tissue engineering [33]. This material has a low rate of hydrolytic degradation, which is
useful for long term demands [32]. PCL is also a good material for supporting cell attachments,
proliferation, and can also be used as a matrix material for cell culture[34]. Table 1 illustrates the
material properties of PCL within its different molecular weights.

Fig. 1. Polymerization of ε-caprolactone [30]
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Table 1. Properties of PCL[32]

Properties
Average molecular weight (Mn/g mol-1)
Density (ρ/g cm-3)
Glass transition temperature (Tg/°C)
Melting temperature (Tm/°C)
Decomposition temperature (/°C)
Inherit viscosity (ηinh/cm3 g1)
Intrinsic viscosity (η/cm3 g1)
Tensile strength (σ/MPa)
Young modulus (E/GPa)
Elongation at break (ɛ/%)

1.7.

Range
530-630 000
1.071-1.200
(-65)-(-60)
56-65
350
100-130
0.9
4-785
0.21-0.44
20-1000

Finite Element Analysis (FEA)

Finite Element Analysis (FEA) is a method of simulating Computer aided design (CAD) objects to predict
deformation and stresses which has become very popular in research, and its goal is accomplishing
accurate results at adequate speed for virtual model or immediate simulation [35][36]. To date, the
majority of simulation works were not accurate enough and mostly concentrated on the visual effects.
Moreover, in tissue engineering area, simulations were done in linear methods which are fast but only
precise for minor deformations because of very compound nonlinear viscoelastic behaviour of human
tissues [37]. Addressing practical issues in joint mechanics will require accurate geometric data,
advanced numerical strategies to calculate the continuum conditions demonstrating the soft tissue
conduct of the structures in the articulating joint, and precise values for the related material
parameters [38]. In this project, mechanical properties of printed scaffolds with different internal
structures were measured by running static tensile, compression tests, and then these parameters
were used for 3D simulation of articular CAD model to predict the deformation and stresses.

2.

Materials and Methods

2.1.

Design and fabrication of PCL scaffolds

2.1.1. Preparation of samples for 3D printing
PCL with molecular weight of 45 000g mol-1 (PCL45) and Pluronic F-127 were purchased from Sigma
Aldrich. To fabricate scaffolds, the PCL was introduced into the high-temperature syringe and
dispensed through a tubular steel needle head. Cubic and cylindrical samples with different strand
sizes were 3D printed and their tensile and compression mechanical properties were measured. A
KIMM 3D printer (Fig. 2) was used to print the PCL structures. Desired structures were modelled using
SolidWorks 2016 software, and the final model was saved in STL format. The STL files were then
exported into Repetier (V2.0.5) and sliced into 21 layers, with each layer height of 0.3mm and 0°-90°
patterns (Fig. 5).
4

3D Bio-Plotter

KIMM Printer

Fig. 2. 3D Bio-Plotter and KIIM Printers

2.1.2. Pressure and Speed Tuning for 3D printing
The KIMMSPS 1000 extrusion 3D printer is capable of extruding fibres varying from 100 µm to 500 µm
at a minimum resolution down to 1 µm. This 3D printer is working in concert with three working
appliances, with an extra attachment for printing in the rotating axis to make scaffolds in the shape of
cylinders and tubes. The machine’s temperature can also be adjusted for melt extrusion printing. The
building process for 3D plotting is dependent on a large number of parameters; especially printing
pressure and speed. It is difficult to calculate all of these in advance for a new material. Therefore, a
series of experiments has to be carried out to find the right settings. One of the best options for finding
the appropriate printing Pressure and Speed is using the Pressure Tuning Parameter and Speed Tuning
Parameter. Under Pressure Tuning Parameter, a fixed Speed was selected, as well as the minimum
and maximum pressure. Also, Under Speed Tuning Parameter, a fixed Pressure was selected, as well
as the minimum and maximum speed. In this process 5 strands were printed within the defined range.
2.1.3. 3D modelling of cubic and cylindrical mechanical samples
The aim of this project is to investigate the relationship between the internal layout of a 3D printed
structure and the mechanical properties. Therefore, two types of cubic and cylindrical samples were
modelled using SolidWorks. When the model was created it was required to be sliced and converted
to G-Code format for 3D printing. For tensile tests, two types of samples with uniform and nonuniform internal structures with external dimensions of 10LX6WX2H mm were modelled: affording
uniform structures with strand sizes (SS) of 1mm (S1), 1.5mm (S1.5), and 2mm (S2), and non-uniform
internal structures with combinations of strand sizes of 2mm and 1mm (S2S1), 2mm and 15mm
(S2S15), 2mm and 15mm and 1mm (S2S15S1) (Fig. 11). For compression tests, Cylindrical models with
5

15mm Diameter, 5mm Height, and strand sizes of S1, S1.5, and S2 for uniform structures, and S2S1,
S2S1.5, and S2S1.5S1 for non-uniform structures were created (Fig. 12).

2.1.4. Modeling and printing of ear structure
The next step in this project was using 3D printers to fabricate ear scaffolds with uniform and nonuniform internal structures which could mimic the mechanical properties of an actual human articular
structure. The correct shape of a scaffold construct is obtained from a human ear by processing
computed tomography (CT scan) data in Materialise Mimics (3D Medical Image Processing Software).
In addition, ear scaffolds were designed using SolidWorks and sliced using repetier. As the ear scaffold
had a complex structure, in some areas support material was required; therefore, envision bio-plotter
(Fig. 2) with two nozzle heads were used for 3D printing of ear scaffolds. Two different types of ear
scaffolds were designed: a uniform internal structure and non-uniform internal structure (Fig. 13).
Since with auto-slicing of the ear structures there was no control on their internal layout, the models
were post-processed and converted to sets of lines sitting on top of each other in 0-90 orders forming
the ear scaffolds. In this project two types of ear scaffolds were 3D printed: uniform internal structure
with strand sizes of 1mm, 1.5mm and 2mm, and non-uniform internal structure with strand sizes of
1mm and 1.5mm.
The distances between the strands of the structures were selected based on Lee et al, where 3D
printed PCL structures with different strand spacings between 1.0 and 1.2 mm were able to reach
tensile moduli similar to the tensile modulus of the auricular cartilage (16 ± 3.3 MPa)[39]. Therefore,
in this project, the influence of the pattern designs with strand spacings of 1.0, 1.5 and 2.0 mm on the
mechanical properties like the tensile modulus and the compression modulus was investigated.
Hence, a range of tensile moduli for the uniform internal structures between 4 – 13 MPa was obtained.
Structures with 3 different grid sizes were printed and then, based on the mechanical properties
results, grid sizes of 1 and 1.5 were chosen to print the hard and soft segments of the ear. The soft
segment of the ear was printed in both grid sizes, while the hard segment was printed only with the
grid size of 1mm.
As mentioned earlier, because of the complexity of the ear structure, support materials were required
to be 3D printed under some areas of the scaffold. The appropriate support material should be biocompatible and easily removable without affecting the mechanical properties of the ear structure.
Therefore, 20 wt. % pluronic acid f127, a bio-compatible and water soluble support material, was
chosen (Fig. 20).
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2.2.

Mechanical Test of 3D printed structures

2.2.1. Mechanical testing of 3D printed PCL structure
In these experiments two types of uniaxial static tensile and compression tests were performed using
a Shimadzu EZ mechanical tester. For each test, three samples with similar internal and external
structures were tested and their standard deviations were calculated using Microsoft excel.
In compression tests, cylindrical samples were tested with 500N uniform pressures at a compression
rate of 10mm/min. Also, for tensile tests, the cubic samples were stretched to their break point at a
rate of 10mm/min (10mm on each side were used for connection to clamps).
2.2.2. Dynamic Mechanical Analysis (DMA)
As PCL is a viscoelastic material, DMA tests were performed in order to investigate the relationship
between elasticity and plasticity of the structures during deformation. Therefore, 60X6x2mm samples
with different strand sizes were modelled and then tested at room temperature using a TA
instruments Q800 DMA with Dual cantilever fixture clamps (Fig. 3). For all tests, multi-strain method
with frequency of 1HZ and amplitude range from 2 to 5000µm were used.

Fig. 3. TA instruments Q800 DMA with Dual cantilever fixture clamps

2.2.3. Mechanical Test of ear scaffold
The ear structure was divided into 6 regions and two types of compressive mechanical tests were
performed on each region using a Shimadzu EZ mechanical tester with 5mm diameter press (Fig. 4).
In the first experiment, a full compressive test was performed and a stress-strain graph was plotted
from which the modulus of elasticity of the scaffold was measured; from the initial region of the graph.
The second experiment was a recovery test measuring the mechanical properties of the ear structure
by applying 20 cycles of compression with 50N Force.
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2.3.

Finite element analysis

After all the mechanical properties of the PCL samples were measured and their modulus of elasticity
was extracted, finite element analysis (FEA) was performed using a SolidWorks simulation nonlinear
method. In this experiment, attempts were made to predict the mechanical behaviour of the
structures under different types of loadings. Therefore, two types of tensile and compression
simulations were performed in these analyses with the Poisson’s ratio of 0.3 which was measured by
an optical method that was explained by Jurvelin et al. [40].
Mesh convergence is one of the issues in computational mechanics that effects the accuracy of the
results. In this project, for FEA analysis, Solid Curvature-based mesh with 4 points Jacobina points were
selected. To be able to mimic the real 3D printed ear structure and to prevent stress convergence
errors during simulation this type of mesh was selected which creates more mesh elements in higher
curvature areas automatically without need for mesh control. Also 0.2mm was chosen for the element
size which noticeably increased the processing time but had two advantages:
1- To help us getting more accurate results closer to the mechanical tests.
2- Prevent stress convergence specially on the corners.
Also, the sharp corners of the structure were modified, by reshaping them to sphere shape to prevent
stress convergence.

To be able to simplify the analysis, the following presumptions were made:
1. The PCL material of structures was assumed to be homogeneous, non-linear.
2. The spreading of the temperature throughout analysing of the scaffolds is uniform.
3. Throughout the FEA analysis, it was assumed that the Poisson ratio is constant.
4. No rotation or translation was allowed for all nodes in contact with the clamps.
5. The contact elements between filaments were assumed to be fully bonded.
6. The filaments diameter is exactly 0.3mm.
7. The filaments are assumed to be straight lines.
In all tensile and compression tests, the models were pulled or pressed until the stage of fracture. The
ear model was also 3D CAD simulated by dividing it into six separate sections and compression load
was applied on each section (Fig. 4). For each sample the maximum Von Mises stress required to
deform the scaffolds was calculated.
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Fig. 4. Six sections of ear scaffold for Mechanical tests and CAD simulations

3.

Results and Discussion

Fig. 5 shows the sliced STL structure using Repetier (V2.0.5). As mentioned before, each structure was
sliced into 21 layers with layer height of 0.3mm and 0°-90° patterns

Fig. 5. Generated sliced pattern for 3D printing

3.1.

Pressure and Speed Tuning for 3D printing

Table 2 and Table 3 illustrate the pressure and speed parameters that were used in our 10 tuning
prints.
Table 2.Pressure tuning parameters

Test

Pressure
Tuning

Pressure 1
Pressure 2
Pressure 3
Pressure 4
Pressure 5

Pressure
(bar)
1
1.38
1.75
2.0
2.5

Speed
(mm/s)
2
2
2
2
2

Temperature
(°C)
120
120
120
120
120

Pressure
(bar)
2.0

Speed
(mm/Sec)
2
9

Temperature
(°C)
120

Table 3.Speed tuning parameters

Test
Speed 1

Speed
Tuning

Speed 2
Speed 3
Speed 4
Speed 5

2.0
2.0
2.0
2.0

6.25
7.5
8.75
10

120
120
120
120

Table 4 and

Table 5 show the effects of pressure and printing speed on printing quality respectively. The results
show that by increasing the pressure, the printed thickness of printed lines increases while by
increasing the speed, its thickness decreases.

Table 4. Microscope images of Pressure tuning prints

Test

Pressure
(bar)

Speed
(mm/s)

Temperature
(°C)

Thickness
(mm)

Pressure
1

1

10

120

0.175

Pressure
2

1.38

10

120

0.138

10

Pressure
3

1.75

10

120

0.171

Pressure
4

2.13

10

120

0.273

Pressure
5

2.5

10

120

0.276

Table 5. Microscope images of Speed tuning prints

Test

Pressure
(bar)

Speed
(mm/s)

Temperature
(°C)

Thickness
(mm)

Speed
1

2.0

5

120

0.291

Speed
2

2.0

6.25

120

0.239

11

Speed
3

2.0

7.5

120

0.131

1Spee
d4

2.0

8.75

120

0.114

Speed
5

2.0

10

120

0.191

3.2.

3D Printed Single Layer Structure

After finding the optimum printing speed (5mm/s) and Pressure (2.5 bar), in the next stage
10X10x10mm single layer squares with different line spacings (1mm, 2mm, 2.5mm) and angles (0°,
45°, 60°) were printed. Table 6 demonstrates nine different single layer 3D printing as well as
microscope imaging of PCL structure with different internal shapes (0°, 45°, 60°, and 1, 2, 2.5 mm
distance) under conditions of: the Pressure: 2.5bar, Speed: 5mm/s, thickness: 0.3mm, and Layer
height: 0.3 mm.
Table 6. Microscope printing images of single layer prints with different internal structures (Scale bar=2mm)

Test

Pressure
(bar)

Speed
(mm/s)

Tempe
rature
(°C)

Layer
Height
(mm)

Angle
(°)

Distance
(mm)

Test
1

2.5

5

130

0.3

45

2

12

Test
2

2.5

5

130

0.3

0

2

Test
3

2.5

5

130

0.3

60

2

Test
4

2.5

5

130

0.3

0

1

Test
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Test
9

3.3.

2.5

5

130

0.3

45

2.5

3D printed Single & Multilayer Structure

At the next stage, a double line test print with the pressure (P) of 2.5 bar and speed (S) of 5 mm/Sec
was performed and the print was checked under the microscope to ensure that the print had the
desired specifications (0.3 mm thickness (T), 2 mm distance (D)). By looking at Fig. 6, it can be seen
that by using the above speed and pressure, the desired thickness was achieved for a 2 layers print.

Fig. 6. Test11: Pressure: 2.5 bar, Speed: 5mm/Sec, thickness: 0.3mm

Next, multi-layer printing was performed with the selected speed and pressure. During this
experiment, in the scaffolds with a larger gap between strands, the lines were sagging before
solidifying, therefore, to be able to get straight lines a fan was used to cool down the filament as soon
as they were printed; which improved the printing quality considerably (Fig. 7).
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A

B

Fig. 7. The effect of using a fan cooling system on the construction of 3D printed sample (A: no fan, B: fan cooled 3D
printed structure)

3.4.

Optical Microscopy

The optical images of printed PCL scaffolds were taken by using a Leica Stereo microscope (M205A).
The microscope images of PCL scaffolds are shown in Fig. 8. According to the figures, in all structures,
the thickness of filaments is 0.3mm and the scaffolds have the strand sizes of 1mm, 1.5mm, and 2mm
respectively.
S1

S1.5

15

S2

Fig. 8. The microscope images of PCL scaffolds with diverse strand size configurations

3.5.

3D modelling and printing of mechanical samples

The major problem with slicing software like Repetier is that they are ideal to be used for fuse
deposition modelling (FDM) method and not bio-purposes, and with auto-slicing there was no control
of the internal distances of the strands. Another problem with the auto-slicing option was the
traversing problem of the nozzle, which means that, in each layer instead of having one continuous
line and having one start and one end point, the nozzle was printing each layer randomly (Fig. 9).
Therefore, to be able to generate 3D mechanical samples with desired pattern, the model was first
modelled as a cubic or cylindrical block and then post-processed and finally converted to a set of lines
sitting on top of each other forming the printing pattern (Fig. 10).

Fig. 9. Traversing problem of nozzle during 3D printing
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Fig. 10. Construction of 3D models

The final 3D design and printed structures are shown in Fig. 11 and Fig. 12. All filaments have the
thickness of 0.3mm and height of 0.3mm.

A
S1

S1.5

S2

B
S2S1

S2S1.5

S2S1.5S1
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Fig. 11. Uniform and non-uniform samples for tensile test – Scale bar=2mm

A
S1

S1.5

S2S1

S2S1.5

S2

B
S2S1.5S1

Fig. 12. Uniform and non-uniform samples for Compression test – Scale bar=2mm

3.6.

3D modelling and printing of ear structures

Fig. 13 shows the final 3D model and printing of uniform (A) and non-uniform (B) ear scaffolds.
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A

B

Fig. 13. Ear scaffold with Uniform (A) and non-uniform (B) internal structure

3.7.

Mechanical testing

3.7.1. Mechanical testing of PCL structure: performing Static Tensile and Compression
Measuring and characterizing the material properties
In both compressive and tensile tests, the force F (N) and deformation d (mm) were recorded, and
calculated stress and strain values were used to plot the stress–strain graphs. In addition, for each
structure, modulus of Elasticity was calculated by using the initial linear section of the stress-strain
curve. In both compression and tensile tests, the PCL scaffolds were elastic and not brittle and
exhibited linear stress-strain behaviour in a small region followed by a yield point, and strain hardening
region and finally disrupter in tensile tests.
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3.7.1.1. Compression and Tensile tests of Uniform Structure
Fig. 15 (A) and (B) illustrate the initial region of Stress-strain graphs in both tensile and compression
tests of uniform internal structures. From these graphs the modulus of elasticity was calculated and
as shown in Table 7, in both compression and tensile tests, the modulus of elasticity of 3D printed
scaffolds is decreased by increasing the strand size of scaffolds. By changing the strand size from S1 to
S1.5 the modulus of elasticity decreased 30% in compression and 33% in tensile tests. Also, by
changing the strand size from S1.5 to S2, the modulus changes 44% in compression and 50% in tensile
tests. This clearly shows that the strand size significantly affects the mechanical properties of printed
structures.
Fig. 15 (A) and (B) also shows that in uniform structures, in both compressive and tensile tests, by
increasing the strand sizes, less force is required to deform the structures. The moduli of Elasticities
measured in these experiments are used for defining the mechanical properties of finite element
analysis of scaffolds. Fig. 14 shows the deformation of a tensile sample (S1). It can be seen that the
load is distributed uniformly along the sample and the necking and fracture has happened in the
middle of the structure. This demonstrates that the structure has a uniform stiffness and consequently
unique mechanical properties along the structure.

Fig. 14. Tensile deformation of uniform structure
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Fig. 15. (A) Initial regions of Tensile Stress-strain Curves of Uniform internal structures; (B) Initial regions of Compressive
Stress-strain Curves of Uniform internal structures. An example of a complete stress-strain curve is shown at top corner
of (A) and (B)
Table 7.Strand sizes and equivalent compressive and tensile modulus of Uniform 3D printed PCL scaffolds.

Experimental
Groups
1

Strand Size(mm)
S1
21

Compressive
Modulus(MPa)
11.533±4.42

Tensile
Modulus(MPa)
13±0.99

Uniform internal 2
structures
3

S1.5
S2

8.82±3.78
5.06±1.83

8.78±0.34
4.37±0.33

3.7.1.2. Compression and Tensile tests of Non-Uniform Structures
Fig. 17 (A) and (B) illustrate the initial region of Stress-strain graphs in both tensile and compression
tests of non-uniform internal structures. From these graphs the modulus of elasticity was calculated
and as shown in Table 8, in both compression and tensile tests, the modulus of elasticity of 3D printed
scaffolds is decreased by increasing the distances between strands of scaffolds which infers that the
scaffolds with higher porosity have lower modulus of Elasticity and consequently larger elasticity. For
instance, comparing S2S1 to S2S1.5 structures, it can be seen that the modulus of elasticity has
decreased by 4% in compressive and 6% in tensile tests while by changing from S2S1.5 to S2S1.5S1
the modulus of elasticity is changing by 10% and 19% respectively. Also, in both uniform and nonuniform structures, by increasing the porosity, less force is required to deform the structure. Fig. 16
shows the deformation of a non-uniform tensile sample (S2 on the bottom and S1 on top). It can be
seen that during deformation, first the bottom part of the sample which has larger strand sizes has
started deforming while the top side has still kept its shape. This demonstrates that the structure has
a different stiffness and consequently varied mechanical properties in its different regions.

Fig. 16. Tensile deformation of non-uniform structure (S2S1)
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Fig. 17. (A) Initial region of Tensile Stress-strain Curves of Non-Uniform internal structures; (B) Initial region of Compressive
Stress-strain Curves of Non-Uniform internal structures. An example of a complete stress-strain curve is shown at top
corner of (A) and (B)
Table 8. Strand sizes and equivalent compressive and tensile modulus of 3D printed Non-Uniform PCL scaffolds.

Experimental
Groups
1

Strand Size(mm)
S2S1
23

Compressive
Modulus(MPa)
54.47±18.21

Tensile
Modulus(MPa)
6.04±0.84

Non-Uniform
internal
structures

2
3

S2S1.5
S2S1.5S1

52.64±12.56
47.32±16.74

5.69±1.35
4.03±0.71

From Table 8, it is obvious that in compression tests, the modulus of elasticity of non-uniform
structures are significantly higher than uniform structures and this could be the effect of the borders
that had to be printed to join the different size of strands together (Fig. 12 (part B)). In further studies,
this issue can be resolved by improving the 3D model of the non-uniform compression samples.
3.7.2. Dynamic Mechanical Analysis (DMA) test
In this experiment a series of DMA tests was performed on the uniform and non-uniform structures
to evaluate the viscoelasticity and the mechanical behaviour of the PCL structures under dynamic
loads.
Fig. 18 shows the storage modulus and loss modulus of different types of uniform and non-uniform
scaffolds. According to the graphs in DMA test, with the increase of strand sizes, the amount of storage
modulus or stored energy which represents the elastic portion of the structures is decreasing. On the
other hand, the loss modulus or the energy that is dissipated as heat and demonstrating the viscosity
of the material is increasing by the increase of the strand sizes of the scaffolds. Also, in all scaffolds
with the uniform internal structures, by increasing the amount of strain amplitude, the storage
modulus is increasing while the loss modulus is decreasing.
In addition, these graphs illustrate that in both uniform and non-uniform structures, by increasing the
density of the material, the amount of viscoelasticity is increasing which proves the direct impact of
internal structure on the mechanical properties of the structure.
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Fig. 18. (A) DMA test results on Uniform internal structures – The relationship between storage modulus and loss
modulus. (B) DMA test results on non-Uniform internal structures – The relationship between storage modulus and loss
modulus

3.8.

3D Printing and Simulation of ear structure

3.8.1. 3D printing of ear scaffold
Fig. 19 shows the different types of 3D printed ear scaffolds with uniform internal structures (S1) (A),
combination of two types of strand sizes (S1.5, S1) (B), and the model and 3D printed
structure with 6 different strand sizes (S0.6S 0.8S 1S 1.2S 1.4S 1.6) (C).
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A

S1

B

S1.5S1

C

Fig. 19. Designed model and Printed pours ear scaffolds with (A) S1 Uniform internal structure, (B) S1S1.5 non-uniform
structure, and (C) S0.6S 0.8S 1S 1.2S 1.4S 1.6mm non-uniform - multi sections internal structure – Scale bar=2mm
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Fig. 20 shows the uses of 20 wt. % pluronic acid f127 as a support material for printing ear structures.
This support can be easily separated from the structure by either cooling down or being washed by
water without damaging the 3D printed scaffold.

Fig. 20.Printing Pluronic acid f127 for support material

3.8.2. Mechanical testing of an ear structure
3.8.2.1. Compression test
Fig. 21 illustrates the initial region of compressive Stress-strain graphs in uniform (A) and non-uniform
(B) ear structures. Table 9, Table 10 shows the compressive modulus in 6 different areas of the uniform
(S1 in all areas), and non-uniform (s1 in areas 1, 2, 3 and S1.5 in areas 4, 5, and 6) ear scaffolds (Fig.22).
By comparing the uniform and non-uniform graphs in these tables, it can be seen that by increasing
the strand sizes in areas 4, 5, and 6, the required force to deform the scaffold has significantly
decreased. This means that for the same scaffolds, by increasing the strand sizes or porosity of the
structure, the force required to deform the structure is decreasing significantly.
Based on these results it can be proven that 3D printing is giving us the ability of changing the internal
layout of the structure to be able to 3D print an ear scaffold with various mechanical properties to
mimic the actual human ear structure.
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Fig. 21. (A) Initial region of compressive Stress-strain Curves of ear scaffold with Uniform (all areas strand sizes=1mm)
(A) and non-uniform (S1 in Areas 1, 2, 3, and S1.5 in areas 4, 5, 6) (B) internal structures; an example of complete stressstrain curve is shown at top corner of (A) and (B)
Table 9. Compression test of Uniform PCL ear scaffolds

Ear with uniform
internal structures

area

Strand Size(mm)

1
2
3
4
5
6

S1
S1
S1
S1
S1
S1
28

Compressive
Modulus(MPa)
1.59±0.12
5.10±0.24
4.43±0.29
6.82±4.74
1.72±0.36
2.33±0.57

Table 10. Compression test of Non-Uniform PCL ear scaffolds

Ear with non-uniform
internal structures

area

Strand Size(mm)

4
5
6

S1.5
S1.5
S1.5

Compressive
Modulus(MPa)
1.63±0.41
1.15±0.61
0.56±0.37

Fig. 22. Compression test of ear scaffold in different regions

3.8.2.2. Recovery Tests
Fig. 23 and Fig. 24 illustrate the Force (N)-Displacement (mm) graphs for uniform and non-uniform
scaffolds respectively. In all samples, a large hysteresis in the first cycle is followed by significantly
smaller ones, indicating that most of the hysteresis occurred in the first cycle. Furthermore, force
softening, which appears as an increase in the strain of the samples, decreased at higher number of
cycles. The results indicate that hysteresis and force softening decrease by increasing the compression
cycles.
Comparing areas 1, 2 and 3, area 1 shows significantly better elastic properties with higher strain,
smaller hysteresis as well as identical loading/unloading paths with minimal variations. Better
elasticity in area 1 could be attributed to its more compact structure. Areas 4, 5 and 6 have been
printed in two different grid sizes of 1.5mm. There is not any significant difference on the compression
curves of area 4 and 5 by increasing the grid size. On the other hand, area 6 with larger grid size shows
perpetual force softening, increased by number of cycles, which is considerably less evident in its
smaller grid size. This can be due to the weaker structure of area 6, which became even weaker when
the structure is printed in larger grid size. Area 4 shows smaller strain at 50N force compared with
areas 5 and 6, which is due to its compact printed structure compared with other areas. Area 5 shows
smaller force softening compared with the other areas. Generally, area 1 shows better elastic
behaviour at 50N force, due to having a more compact structure and more layers at that area. These
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graphs show that the regions 1, 2, and 3, which are harder, have more uniform structures with better
elastic recoveries compared with softer regions. These graphs also show that the strain is increasing
when the strand sizes increase. In conclusion, the softer regions are having a much more non-uniform
strain behaviour compared with regions with smaller strand sizes, which are stiffer.
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Fig. 23. Recovery tests (20 Cycles and 50N) on the Uniform internal structure (all areas strand sizes=S1)
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Fig. 24. Recovery tests (20 Cycles and 50N) on the non-uniform internal structure (S1 in areas 1, 2, 3, and S1.5 in areas 4,
5, 6)

3.9.

Finite Element Analysis (FEA) of PCL structures and correlation of

results with mechanical test
Fig. 25 and Fig. 26 show the nonlinear simulation results for tensile and compressive samples for
uniform and non-uniform internal structures. All stress results for tensile and compression tests are
available for each element under different loading conditions.
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3.9.1. Finite element analysis of non-linear PCL scaffold with Uniform structure
Table 11 shows the maximum von mises stress for different types of uniform structures (S1, S1.5, S2).
It can be seen that, similar to mechanical tests, in both tensile and compressive modellings, the
maximum stress required to deform the structure is reduced by increasing the internal strand sizes of
the scaffolds, which means a reduction in rigidity of the scaffolds. Fig. 25 shows the deformation of
the structures in both tensile and compression analyses.

A
S1

S2

S1.5

B
S1

S1.5

S2

Fig. 25. (A) 3D CAD simulation of scaffolds with uniform internal structure: tensile (A), compression (B) (Red sections have
the highest displacement in the structures) – Scale bar=2mm.
Table 11.Finite Element Analysis of Uniform PCL scaffolds
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Uniform internal
structures

Experimental
Groups
1
2
3

Strand Size(mm)
S1
S1.5
S2

Compressive
Stress(MPa)
0.4
0.31
0.23

Tensile Stress
(MPa)
6.29
3.59
2.19

3.9.2. Finite element analysis of non-linear PCL scaffold with Non-Uniform structure
Table 12 shows the maximum von-mises stress for different types of non-uniform structures. The
results demonstrate that in both tensile and compressive modellings, the maximum stress required to
deform the structure decreases by increases in strand sizes of the internal structures. Fig. 26 also
illustrates the deformation of the structures in both tensile and compression analyses.

A
S2S1

S2S1.5
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S2S1.5S1

B
S2S1

S2S1.5

S2S1.5S1

Fig. 26. (A) 3D CAD simulation of scaffolds with non-uniform internal structure: (A) tensile, (B) compression (Red sections
have the highest displacement in the structures) – Scale bar=2mm.
Table 12.Finite Element Analysis of Non-Uniform PCL scaffolds

Non-Uniform
internal
structures

Experimental
Groups
1
2
3

Strand Size(mm)
S2S1
S2S1.5
S2S1.5S1

Compressive
Stress(MPa)
0.35
0.26
0.11

Tensile
Stress(MPa)
0.488
0.34
0.35

3.9.3. Finite element analysis of ear structures with uniform internal structure
In this section, the ear scaffold was divided into six different sections (Fig. 19 (A)) with a uniform strand
size of 1 mm. Fig. 27 shows the total deformation of each section under compressive force. From
Table 13 in can be seen that the maximum von mises stress in each section is varied because of
different material density in each section.
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1

2

3

4

5

6

Fig. 27.3D CAD simulation of ear scaffold with uniform internal structure in six different sections (S1) – Scale bar=2mm.
(Red sections have the highest displacement in the structures).
Table 13. Elastic modulus on the scaffolds in different areas – Uniform structure

Compressive
Stress(MPa)

Area1

Area2

Area3

Area4

Area5

Area6

0.28

0.41

0.22

0.38

0.33

0.35

3.9.4. Finite element analysis of ear structures with non-uniform internal structure
In this section, a non-uniform ear scaffold with the strand sizes of S1 in sections 1, 2, and 3 and S1.5
in sections 4, 5, and 6 was modelled (Fig. 19 (A)). As the internal parameters of sections 1, 2, and 3
were kept to S1, therefore their mechanical properties have not changed and are similar to the
uniform ear structure. Fig. 28 shows the overall deflection of a non-uniform ear scaffold with strand
sizes of S1.5 in areas 4, 5, and 6. The maximum von mises stress in each different section is shown in
Table 14. By comparing Table 13 and Table 14, it can be seen that, the maximum von mises stress of
non-uniform ear scaffold in the areas 4, 5, and 6 has reduced with the increase in the strand sizes,
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which means less force was needed to deform the structure. From these results it can be concluded
that by changing the internal properties of the ear structure, its mechanical properties has changed.
4

5

6

Fig. 28. 3D CAD simulation of ear scaffold with non-uniform internal structure (S 1.5 for areas 4, 5, 6) – Scale bar=2mm.
(Red sections have the highest displacement in the structures).
Table 14. Elastic modulus on the scaffolds in different areas – Non-Uniform structure

Compressive
Stress(MPa)

Area4

Area5

Area6

0.34

0.28

0.23

In this study the behaviour of the FEA models was assumed to be exactly corresponded with the
mechanical tests, although the mechanical tests might be different, significantly, from the FEA results.
The first potential error is presented by the conversion from the CAD into the FEA model; as well as
possible errors during 3D printing of the scaffolds. Also, in FEA modelling all the test conditions like
poison’s ratio, temperature, tolerances are assumed to be constant while they might be changing
during the mechanical tests. Finally, next main reasons for this could be in FEA modelling, the contact
elements between printed lined are assumed to be fully bonded. However, the actual contact
parameters between filaments should be measured to be able to get more accurate results in finite
element analysis. These issues could be focused on in future studies. Possible errors are concluded
from the assumptions listed in the section of materials and methods.
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4.

Conclusion

In conclusion, the results show that the mechanical properties of the 3D printed scaffolds, in both
uniform and non-uniform structures, were affected by the strand sizes of the scaffolds. In other words,
it was ascertained that, by reducing the distances between strands of the structure, its modulus of
elasticity increases; which means more force is required to deform the structure. On the other hand,
by increasing the strand distances, the modulus of elasticity of the structure decreases and less force
is needed to deform the structure. In addition, it was demonstrated that different zones of a nonuniform 3D printed scaffold, which have different internal structures, exhibited different mechanical
properties.
In FEA analysis, it was also proven that by increasing the strand size of the internal structure, the
maximum stress required to deform the structure decreases.
Combining this knowledge with 3D printing technology, made it possible to 3D print an ear structure
comprised of different zones with different mechanical properties that mimics the human ear.
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5.

Appendix

5.1.

Bioethics

“Bioethics” is the study of understanding which decisions should be taken with respect to human
health and people’s lives, giving due consideration to the environment and societal beliefs[41]. In
bioethics some certain questions about a human’s rights should be answered. Questions like: if certain
treatments should be done on patients or not, or if these treatments have any positive or negative
impact on the society or environment. It can also involve issues in people’s lives. For example: should
a new medicine be tested whether in vitro, on animals, or even on humans. Sometimes In bioethics,
it requires different types of experts to work on a bioethics issue. Experts in areas like: low, nursing,
philosophy, etc. So, in conclusion, bioethics is a set of standards for treatment of patients, and to help
researchers and medical people. Every doctor, nurse or a general health care professional should know
their patients’ rights and know how to treat them based on medical ethics. On the other hand, every
patient should know their rights and the power to reject a medical method and, thanks to bioethics,
these days each patient should know their illness, the length and way that they are going to be cured.
One of the areas which has many attractions to researchers is Stem cells. These cells are able to
convert to different types of specific tissues; therefore, they can be used for many patients with little
chance of cure[42]. Because of the great capabilities of stem cells in medical treatments, a prolific
growth in the number of stem cell clinics has ensued, however, some of them are involved in illegal
activities like below[42]:
•

In Hungary, police arrested four people for illegal use of human embryonic stem cells for different
types of illegal and unlicensed treatments[43].

•

In Costa Rica, a clinic called Cell Medicine, illegally treated more than 400 foreign patients with
stem cells for nearly 10 years, and were shut down by the country’s health Ministry because they
couldn’t provide any scientific proof for their treatments at their clinic. However, after the shutdown, the Cell medicine clinic continued their business by moving to a bigger place with more
facilities in Panama City[42].

•

In 2009, China made a new rule requiring any researcher or clinics working with Stem Cells to
provide clinical data as well as providing approval from the China health ministry[44]. It is believed
that China has more than a hundred laboratories working with Stem Cells; which is the largest in
the world, offering therapies for Multiple Sclerosis, Lupus, Muscular Dystrophy, and spinal cord
injuries, and is now set to expand to Malaysia, Thailand and the Philippines[45].

Recently, the use of additive manufacturing (3D Printing) has been used in many innovations such as:
engineering, art, education, manufacturing and medicine. In medical research, this technology has
38

helped scientists to be able to 3D print biocompatible materials like Multicellular tissues and organs.
This technology also solve additional difficulties such as types of material, cell types, growing of cells
,differentiation factors and other techniques which are impossible to achieve in the current traditional
transplantation methods [46] New research on regulating 3D printing totally assumes that the same
regulations on non-biological materials should be used on biological materials, nevertheless, these
two regulations are totally different as printing bio-medical materials presents different public policy
deliberations [47].
5.1.1. Researchers and clinicians in developing new therapies
The main purpose of clinical research is to develop research findings to increase human’s health and
the comprehension of human’s physiology, behaviour, and other qualities of particular organism or
class of organisms[42]. For every research done in Australia, it should be corresponded with high
ethical and scientific standards and therefore the risk of any injury to the participants is low.
Based on application of the values Section1, it requires any risks to the participants during the research
to be evaluated, and it will be ethically accepted if the research proves the benefits to the participants
or good of others[41].
Let’s give a short description about risk: Risk is a "danger, hazard; exposure to mischance or risk".
Hence, to put oneself "at risk" means to contribute voluntarily or involuntarily in an event or activity
that could cause injury, loss or damage. [The Oxford English Dictionary]. Some involuntary risks are:
lightning fatality, Fire related accidents, and accidental poisoning. On the other hand voluntary risks
are like: Automobile accidents, Skydiving accidents[41]. So, to minimise the risk or possibility of
exploitation, in every research project, it should be assessed, managed, and minimised by the
researchers and ensuring that the research themes are not only used but adhered to with admiration
while they contribute to social service [41].
The bio-printing research done on bio-printed products involve risk both inside and outside the human
body and invoke distinctive ethical concerns. For instance, the source of a product which is going to
be used inside a patient could be an issue in some societies or religions[48].For researchers and clinics
developing new therapies and medical technologies using bioprinting, it would be so challenging for
them to be able to test their medicine on real humans (especially in Australia and United states); as
for example testing of organs and clinical trials to be transplanted in America could take many years
to get permission from the Food and Drug Administration, whereas it might not take long to get the
same permission in countries with easier regulations[49]. Unlike non-biological materials, different
public policy requires to be considered when printing from biological materials. Also, experimenting
with humans requires compliance with strong political regulatory and ethical debates[50].
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5.1.2. Current and future patients in having access to safe, tested and effective
treatments
Compared with traditional organ transplantation, there are some advantages for patients using 3D
printed organs. Bio-printing is having a wide range of benefits with very little risks. It is a big step for
scientists to be able to help society by printing body parts and saving lives. 3D printed body parts can
be really helpful, especially where there is a high demand for the parts in the countries with a large
population or during critical situations like war, and patients do not need to wait for quite a while to
find a donor. In addition, bio-printed organs can be built customised for each patient and this could
increase the chance of acceptance of the organ[51]. However, there are some concerns in using this
emerging technology. For instance, for countries like China and India with large populations and not
an equal access to health care, having access to this type of treatment could cause imbalanced issues.
In addition, some bio-printed body parts like the heart could be really expensive and not many people
can afford them[52].
As mentioned before, current bio-printing regulations assume the same regulations that apply for
other areas of non-biological 3D printing technologies; non-biological parts are ready to be used
whereas biological parts like hand or leg need to be implanted by surgeons or doctors. Furthermore,
printing the biological materials requires different public policy factors compared with non-medical
parts. Also, because bioprinting involves human genetic materials, there is a concern for higher
security than regular 3D printing[53]. Bio-printing is also different to synthetic biology. Although they
both should be done by doctors and surgeons, bio-printing is more accessible and requires higher
certainty than synthetic biology. Furthermore, although organ transplantation and bioprinting
contains human genetic materials, they do not come from a similar source; transplanted organ comes
from another human or animals while a bio-printed part comes from the patient’s own genetic source,
therefore, the possibility of rejection reduces in bio-printing. Thus bio-printing regulations should be
different to organ transplantation laws[54].
As 3D printers and bio-printers can both use the same hardware, almost everyone can have a printer
in their home and print whatever they want. Therefore, regulating bioprinting requires standards
instead of rules[55]. The general idea of bioprinting is mostly positive. People are really excited about
bioprinting issues and its capabilities but, they are intolerant of risk involving any bio-printed parts.
People usually prefer the ideas that benefit the whole society instead of specific groups of people.
They prefer that everybody in the society could afford the technology, and also like to observe the
evidence of the success of a new drug or device[56].

The method of assessing a novel high-risk device or medicine is different in Europe and United States.
The European system is relying on safety and execution of the new device or drug while in U.S.
premarket assessment of safety and performance is necessary which leads to two different clinical
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cases (Table 15). In Europe, the required evidence of clinical test is lower than what’s needed in
US[57].
Table 15. The arrangement of clinical growth and timing of the market presenting new high-risk devices in the US and
Europe

Theoretical order over time
Exploratory clinical
Confirmatory clinical
trails
trials (RCTs)
CE mark
system in
Europe

FDA PMA
process in
the US

Market presenting
based on single-arm
trials demonstrating
safety and performance

Health technology
assessment
Requires safety and
efficiency/effectiveness
data for the
assessment, that might
contain an evaluation
of cost- adequacy

Market introduction
depends on RCTs
demonstrating
“effectiveness/efficacy”
and safety

In Europe, patients have a choice of having earlier access to a possible curing device or medicine but
they have to accept any risk of failure (they might also have to pay for any possible costs)[57]. Medical
devices are classified in both Europe and America based on the chance of harm they cause to patients,
with class III instruments demonstrating the highest risk class which needs to go through a premarket
approval process in the United States. In Europe, new high-risk medical devices should be assessed
through a structure of CE (Conformity European) marking instead of being assessed for a premarket
review by European Authorities or Member State. This premarket assessment of device is done only
once for the whole European market. On the other hand, in America the products will also be
controlled randomly (Randomize control trials (RCTs)) which is the highest standard for recording of
revealing any increase in efficacy and clinical safety[58]. Also, under Premarket Approval procedure,
each organization should indicate sensible assurance of the safety and efficacy of its device for its
desired use[59].
5.1.3. Those patients who might be involved as experimental subjects in clinical testing
One of the main concerns in research ethics is to minimise the amount of participant’s injuries during
the clinical experiments[60]. However, based on the Nuremburg code, it is assumed that all patients
are at the risk of injury during medical testings[61]. In addition, the Belmont Report contains the
necessities for the informed permission of all clinical research contributors[62]. Because bio-printing
is a kind of new technology, people who are involved in 3D printing experiments might face some
issues that no one has ever faced. As mentioned above, bio-printing technology is an emerging
technique in the world, so its results and developments are so interesting for people all around the
world, so it is a great source for media to follow up. Patients who undergo clinical experiments should
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be aware of this attention and should be ready physiologically and mentally be ready to deal with.
Couple of weeks ago I read a news that the world's first face transplant recipient, Frenchwoman
“Isabelle Dinoire”, died "after a long illness". (6 Sep 2016, the Telegraph News). She lost her face from
being bitten by her dog which made her to stay at home, but in 2005 she received a chin, nose, and
lips of a brain-dead donor. Although this transplantation gave her a new life and enabled her to talk
and go out without feeling different to other people, but as the first human who received a facial
transplant, she was always under a lot of attention by media which made her uncomfortable and
eventually depressed! Bio-printing can also be used in emergency situations for patients who lose a
body part in an accident or war. Imagine a bike rider who loses his leg in a car accident, his leg can be
modelled by taking a MRI picture of the other leg, mirroring it and printing, isn’t this fabulous? Or
assume a baby who is born with only one ear, the other ear can be scanned, printed, and finally
implanted for him/her, and the kid can continue to have a normal life without being scared of being
bullied at school.
On the other hand, this technology can’t be accepted by everyone easily. There are some religions
who do not believe in using of any external part in their body. For example, in a situation where a guy
with this belief losing his kidney and there is no donor and the guy will lose his life if he does not get
one within 24 hrs, the surgeons are able to print the kidney using cells that they got from a donor. If
this guy accepts the new kidney, he should always think about this issue of whether this external
subject is accepted in his religion or not. In addition, in bio-printing, the material and source of them
should be specified as well. For instance, in Islam men are advised not to wear gold, so printing a gold
bone for a male patient with Islamic beliefs can cause some conflicts for him.
Although 3D printing of human organs can be very good in medical conditions, however, one of the
main considerations in 3D printing body parts is that whether we should use a 3D printer for human
organs improvements. This technology can be used to improve the human’s power and capabilities.
For instance, metal bones can be printed and replaced for human bone which can be 3 times stronger.
Also, imagine printing stronger muscles which could give humans much more power. Although this
sounds really interesting and can be useful in many respects, it can cause a lot of problems if the
technology gets abused by some people. For instance, imagine if athletes use these 3D printed muscles
in their competition, so running in an Olympics could be meaningless! There would be a competition
between technologies instead of humans.
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